rp3,cisplatin,gemcitabine,paclitaxel
replimune
[]
#gi23 with eagerly awaited oral on swog 1815: gem cis +/- nab-pac
primary ep of os not met. more is not always better.
however, 1st rp3 trial in this disease! the def of a successful trial: "collaboration, coordination, &amp; answers a meaningful question." 
Oncologist | Focus on #NETs | Mom | she/her 
Division Chief, GI Oncology @YaleCancer | Consultant Editor @JCO_ASCO |
Tweets mine | ASCO FCOI: https://t.co/UuqIAQ5Civ